Aug 2026
Large B-Cell Lymphoma After CD19 CAR-T Failure: Updated Real-World Outcomes, Prognostic Factors, and Prediction Models.
Background Outcomes after CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy failure in relapsed or refractory large B-cell lymphoma (LBCL) remain poor, and prognostic tools to guide subsequent management are limited. We evaluated real-world outcomes after CAR-T failure and developed clinical prediction mod...
S. Kungwankiattichai, Sanjog Bastola, Manoj Rai et al.
· Transplantation and Cellular... · 0 citations